Clinical management of Staphylococcus aureus bacteremia
Authors:
Simona Arientová; Michal Holub
Authors‘ workplace:
Klinika infekčních nemocí 1. LF UK a ÚVN – VoFN, Praha
Published in:
Čas. Lék. čes. 2021; 160: 139-142
Category:
Review Article
Overview
Staphylococcus aureus (SAB) bacteremia is very serious and often fatal infection with the high incidence and lethality. Diagnosis of SAB must be followed by an appropriate diagnostic and therapeutic process. From the point of view of proper SAB management, it is essential to find the primary source of infection, which can be skin and soft tissue infections, catheter infections, infectious endocarditis, osteomyelitis, pneumonia or abscesses with hematogenous spread. After the SAB has been identified, it is crucial to determine the appropriate examination and treatment procedure in close collaboration with an infectious disease specialist, clinical microbiologist and clinical pharmacist.
Keywords:
Staphylococcus aureus – staphylococcal infections – Bacteremia – quality of health care
Sources
1. ten Oever J, Jansen JL, van der Vaart TW, et al. Development of quality indicators for the management of Staphylococcus aureus bacteriaemia. J Antimicrob Chemother 2019; 74: 3344–3351.
2. Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28: 603–661.
3. Vogel M, Schmitz RP, Hagel S, et al. Infectious disease consultation for Staphylococcus aureus bacteremia – a systematic review and meta-analysis. J Infect 2016; 72: 19–28.
4. van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25: 362–386.
5. Forsblom E, Kakriainen A, Ruotsalainen E, et al. Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation. Eur Geriatr Med 2018; 9: 355–363.
6. Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009; 48 (Suppl. 4): S231–S237.
7. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36(1): 53–59.
8. Anantha RV, Jegatheswaran J, Pepe DL, et al. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open 2014; 2(4): E352–E359.
9. Paulsen J, Solligard E, Damas JK, et al. The impact of infectious disease specialist consultation for Staphylococcus aureus bloodstream infections: a systematic review. Open Forum Infect Dis 2016; 3: ofw048.
10. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791–797.
11. Austin ED, Sullivan SB, Whittier S, et al. Peripheral intravenous catheter placement is an underrecognized source of Staphylococcus aureus bloodstream infection. Open Forum Infect Dis 2016; 3: ofw072.
12. Kourtis AP, Hatfield K, Baggs J, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections – United States. MMWR Morb Mortal Wkly Rep 2019; 68: 214–219.
13. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. Jama 2012; 308: 50–59.
14. Chang FY, MacDonald BB, Peacock JE jr., et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003; 82: 322–332.
15. Le Moing V, Alla F, Doco-Lecompte T, et al. Staphylococcus aureus bloodstream infection and endocarditis – a prospective cohort study. PLoS One 2015; 10: e0127385.
16. Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014; 68: 242–251.
17. Holland TL, Arnold C, Fowler VG jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014; 312: 1330–1341.
18. Thwaites GE, Scarborough M, Szubert A, et al. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteriaemia: the ARREST RCT. Health Technol Assess 2018; 22: 1–148.
19. Willekens R, Puig-Asensio M, Ruiz-Camps I, et al. Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study. Clin Infect Dis 2019; 69: 381–387.
20. Heriot GS, Tong SYC, Cheng AC, et al. Clinical variation in the use of echocardiography in Staphylococcus aureus bacteriaemia: a multi-centre cohort study. Eur J Clin Microbiol Infect Dis 2018; 37: 469–474.
21. Bolhuis K, Bakker LJ, Keijer JT, et al. Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2018; 37: 1553–1562.
22. Bai AD, Showler A, Burry L, et al. I mpact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015; 60: 1451–1461.
23. Forsblom E, Ruotsalainen E, Ollgren J, et al. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 56: 527–535.
24. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 1000–1008.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
2021 Issue 4
Most read in this issue
- Optimizing clinical approaches to COVID-19 patients in primary care
- COVID-19-free workplace: Measuring the level of antibodies against coronavirus as a basis for testing strategy in companies
- What is the immunity of high school students to coronavirus?
- How Czech and Slovak vascular surgeons and nephrologists accept recommendations of the European Society of Vascular Surgery – survey study